Q: What is Glyxambi used for?

Glyxambi is used to treat type 2 diabetes mellitus .

Q: How does Glyxambi work?

How Glyxambi Works Glyxambi is a combination of two drugs, empagliflozin and linagliptin. Each component targets a different process in the body to manage blood glucose (sugar) levels. Empagliflozin Empagliflozin belongs to a class of drugs called sodium-glucose co-transporter 2 (SGLT2) inhibitors. It works primarily in the kidneys. Under normal conditions, the kidneys filter sugar out of the blood and then reabsorb it back into the bloodstream. Empagliflozin blocks this reabsorption process, which allows the excess sugar to be removed from the body through urination. Linagliptin Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by increasing the levels of natural substances known as incretin hormones. These hormones help regulate blood sugar in two ways: They signal the pancreas to release more insulin, especially after eating a meal. They signal the liver to produce less glucose. By combining these two mechanisms, Glyxambi helps the body remove excess sugar and improves the body's natural ability to regulate sugar levels throughout the day.

Q: What are the active ingredients in Glyxambi?

The active ingredients in Glyxambi are linagliptin and empagliflozin .

Q: What are the side effects of Glyxambi?

Common side effects of Glyxambi may include: urinary tract infection genital yeast infection increased urination Always consult with a healthcare professional about potential side effects.

Q: What is the dosage of Glyxambi and how do I take it?

How to Take Glyxambi Glyxambi is a tablet taken by mouth once every day. It is generally recommended to take this medication in the morning. You may take it with or without food. Missed Dose If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and return to your regular timing. Do not take two doses at the same time to make up for a missed one. General Instructions Follow the specific instructions provided by your healthcare professional regarding your treatment plan. Try to take your medication at the same time each day to help you remember. Swallow the tablet whole; do not crush or chew the medication. Store the tablets at room temperature, away from excess heat and moisture.

Q: Is Glyxambi safe during pregnancy and breastfeeding?

Pregnancy There is limited data regarding the use of Glyxambi in the first trimester of pregnancy. However, based on animal studies, the medication may cause harm to a developing baby's kidneys if taken during the second and third trimesters. Because of these potential risks, healthcare providers typically recommend discontinuing Glyxambi during these stages of pregnancy. If you become pregnant or plan to become pregnant, consult your healthcare provider to discuss alternative methods for controlling blood sugar levels. It is important to manage diabetes effectively during pregnancy to avoid complications for both the parent and the baby. Breastfeeding It is not known if the components of Glyxambi pass into human breast milk. Due to the potential for serious adverse reactions in a nursing infant, particularly concerning kidney development, using this medication while breastfeeding is not recommended. You should talk to your doctor about whether to stop breastfeeding or stop taking the medication, taking into account the importance of the drug to your health.

Q: What forms and strengths does Glyxambi come in?

Available Forms Glyxambi is supplied as a film-coated tablet for oral administration. It is a fixed-dose combination therapy, which means each tablet contains two separate active ingredients: empagliflozin and linagliptin. Appearance The tablets are triangular in shape and are film-coated. The color of the tablet varies to distinguish between the different available options.

Q: What is the FDA approval status of Glyxambi?

FDA Approval Status The U.S. Food and Drug Administration (FDA) approved Glyxambi in January 2015. It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is not approved for the treatment of type 1 diabetes or diabetic ketoacidosis. Regulatory Safety Communications The FDA has issued several safety communications and required label changes for the classes of drugs contained in Glyxambi. These updates focus on the following risks: Ketoacidosis: Labels for SGLT2 inhibitors, such as the empagliflozin component of Glyxambi, were updated to include warnings about the risk of ketoacidosis. This is a serious condition where the body produces high levels of blood acids called ketones. Serious Infections: The FDA has identified risks of serious urinary tract infections that may lead to hospitalization. Additionally, regulatory monitoring has identified rare but severe necrotizing fasciitis of the perineum (Fournier's gangrene) associated with the SGLT2 inhibitor class. Heart Failure: Regulatory reviews have examined the potential risk of heart failure associated with DPP-4 inhibitors, the class of drugs that includes linagliptin. Glyxambi is not a controlled substance and does not currently have a boxed warning.

Question 1

What is Glyxambi?

Accepted Answer

Glyxambi is a combination therapy that contains the active ingredients empagliflozin and linagliptin. These components belong to different classes of medications known as sodium-glucose co-transporter 2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors.

The medication works through multiple pathways to help the body regulate glucose levels. By combining these two classes of medicine, the therapy provides a multi-faceted approach to glycemic control.

Question 2

What is Glyxambi used for?

Accepted Answer

Glyxambi is used to treat type 2 diabetes mellitus.

Question 3

How does Glyxambi work?

Accepted Answer

How Glyxambi Works

Glyxambi is a combination of two drugs, empagliflozin and linagliptin. Each component targets a different process in the body to manage blood glucose (sugar) levels.

Empagliflozin

Empagliflozin belongs to a class of drugs called sodium-glucose co-transporter 2 (SGLT2) inhibitors. It works primarily in the kidneys. Under normal conditions, the kidneys filter sugar out of the blood and then reabsorb it back into the bloodstream. Empagliflozin blocks this reabsorption process, which allows the excess sugar to be removed from the body through urination.

Linagliptin

Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by increasing the levels of natural substances known as incretin hormones. These hormones help regulate blood sugar in two ways:

They signal the pancreas to release more insulin, especially after eating a meal.
They signal the liver to produce less glucose.

By combining these two mechanisms, Glyxambi helps the body remove excess sugar and improves the body's natural ability to regulate sugar levels throughout the day.

Question 4

What are the active ingredients in Glyxambi?

Accepted Answer

The active ingredients in Glyxambi are linagliptin and empagliflozin.

Question 5

What are the side effects of Glyxambi?

Accepted Answer

Common side effects of Glyxambi may include:

urinary tract infection
genital yeast infection
increased urination

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Glyxambi?

Accepted Answer

Glyxambi belongs to the SGLT2 inhibitor and DPP-4 inhibitor combination drug class.

Question 7

What is the dosage of Glyxambi and how do I take it?

Accepted Answer

How to Take Glyxambi

Glyxambi is a tablet taken by mouth once every day. It is generally recommended to take this medication in the morning. You may take it with or without food.

Missed Dose

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and return to your regular timing. Do not take two doses at the same time to make up for a missed one.

General Instructions

Follow the specific instructions provided by your healthcare professional regarding your treatment plan.
Try to take your medication at the same time each day to help you remember.
Swallow the tablet whole; do not crush or chew the medication.
Store the tablets at room temperature, away from excess heat and moisture.

Question 8

Is Glyxambi safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There is limited data regarding the use of Glyxambi in the first trimester of pregnancy. However, based on animal studies, the medication may cause harm to a developing baby's kidneys if taken during the second and third trimesters. Because of these potential risks, healthcare providers typically recommend discontinuing Glyxambi during these stages of pregnancy.

If you become pregnant or plan to become pregnant, consult your healthcare provider to discuss alternative methods for controlling blood sugar levels. It is important to manage diabetes effectively during pregnancy to avoid complications for both the parent and the baby.

Breastfeeding

It is not known if the components of Glyxambi pass into human breast milk. Due to the potential for serious adverse reactions in a nursing infant, particularly concerning kidney development, using this medication while breastfeeding is not recommended. You should talk to your doctor about whether to stop breastfeeding or stop taking the medication, taking into account the importance of the drug to your health.

Question 9

What forms and strengths does Glyxambi come in?

Accepted Answer

Available Forms

Glyxambi is supplied as a film-coated tablet for oral administration. It is a fixed-dose combination therapy, which means each tablet contains two separate active ingredients: empagliflozin and linagliptin.

Appearance

The tablets are triangular in shape and are film-coated. The color of the tablet varies to distinguish between the different available options.

Question 10

What is the FDA approval status of Glyxambi?

Accepted Answer

FDA Approval Status

The U.S. Food and Drug Administration (FDA) approved Glyxambi in January 2015. It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is not approved for the treatment of type 1 diabetes or diabetic ketoacidosis.

Regulatory Safety Communications

The FDA has issued several safety communications and required label changes for the classes of drugs contained in Glyxambi. These updates focus on the following risks:

Ketoacidosis: Labels for SGLT2 inhibitors, such as the empagliflozin component of Glyxambi, were updated to include warnings about the risk of ketoacidosis. This is a serious condition where the body produces high levels of blood acids called ketones.
Serious Infections: The FDA has identified risks of serious urinary tract infections that may lead to hospitalization. Additionally, regulatory monitoring has identified rare but severe necrotizing fasciitis of the perineum (Fournier's gangrene) associated with the SGLT2 inhibitor class.
Heart Failure: Regulatory reviews have examined the potential risk of heart failure associated with DPP-4 inhibitors, the class of drugs that includes linagliptin.

Glyxambi is not a controlled substance and does not currently have a boxed warning.

Question 11

What should I know about Glyxambi and cost?

Accepted Answer

Factors Influencing Cost

The price of Glyxambi can vary based on several factors:

Insurance Coverage: Your out-of-pocket costs are determined by your specific health insurance plan, including your deductible and copayment tier. Most commercial plans and Medicare Part D plans provide coverage for Glyxambi, though it may be placed on a higher tier.
Pharmacy Selection: Prices may differ between retail pharmacies, and mail-order options may offer different pricing structures.
Generic Availability: Glyxambi is a brand-name medication containing two active ingredients (empagliflozin and linagliptin). There is currently no generic version available, which generally makes it more expensive than older, generic diabetes medications.

Financial Assistance Programs

The manufacturer may offer savings cards or patient assistance programs to help reduce the cost for eligible individuals. These programs are often available to patients with commercial insurance or those who are uninsured, though restrictions typically apply to those covered by government programs like Medicare or Medicaid.

Prior Authorization

Some insurance providers may require prior authorization before they will cover Glyxambi. This process involves your healthcare provider submitting documentation to the insurance company to justify the medical necessity of the medication.

Glyxambi

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Glyxambi

Hospitals.net Disclosure